The IWMF raised more than five million dollars for WM medical research
The IWMF raised more than 60 support groups in North America and nearly 20 others world-wide
The IWMF has a current worldwide membership of nearly 4,000
IWMF-TALK is a wonderful place to share information and learn from other survivors
Each year 1,500 new cases of Waldenstrom's macroglobulinemia are diagnosed in the USA
Volunteers at the IWMF Telephone Lifeline are waiting to share their experiences with you
You can order DVD recordings of past WM Educational Forums online or by mail
All IWMF programs and services are funded by WM survivors, caregivers, friends, and family
Find Helpful Information
Find Support and More
On February 12, 2013, it was announced that the FDA granted breakthrough therapy designation for ibrutinib specifically for use with WM and mantle cell lymphoma. This is the FIRST time any drug has been specifically given approval for the treatment of WM, and holds much promise as it continues into Phase III trials. Read more in the IWMF press release about it!
French version of press release: Communique de presse - Bulletin Special.
Last Updated: 1/29/2015